Cargando…
Fluoxetine Administration in Juvenile Monkeys: Implications for Pharmacotherapy in Children
Fluoxetine therapy has been approved for children with major depressive disorder and obsessive compulsive disorder for over 14 years and has expanded to other childhood behavior disorders. As use increases, more detail on fluoxetine effects during juvenile brain development can help maintain safe an...
Autores principales: | Golub, Mari S., Hogrefe, Casey E., Sherwood, Richard J., Turck, Christoph W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809484/ https://www.ncbi.nlm.nih.gov/pubmed/29473029 http://dx.doi.org/10.3389/fped.2018.00021 |
Ejemplares similares
-
Cognitive performance of juvenile monkeys after chronic fluoxetine treatment
por: Golub, Mari S., et al.
Publicado: (2017) -
Identifying individual differences of fluoxetine response in juvenile rhesus monkeys by metabolite profiling
por: He, Y, et al.
Publicado: (2014) -
Delineation of biomarkers and molecular pathways of residual effects of fluoxetine treatment in juvenile rhesus monkeys by proteomic profiling
por: Yan, Yu, et al.
Publicado: (2023) -
Long-Term Fluoxetine Administration Causes Substantial Lipidome Alteration of the Juvenile Macaque Brain
por: Tkachev, Anna, et al.
Publicado: (2021) -
Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?
por: Sakaria, Rishika P., et al.
Publicado: (2022)